News
Shares in MaaT Pharma (Euronext: MAAT), a French microbiome company in oncology, closed 25% higher Tuesday. The company ...
German drugmaker STADA Arzneimittel has reported record earnings on revenues growth in its financial first quarter.
Shanghai-based Mabwell Bioscience (SH: 688062) has secured approval from the Chinese regulator for its first locally ...
Taiwanese biotech PharmaEssentia (TWSE: 6446) is preparing to seek an expanded US label for its long-acting interferon ...
Germany-based mental health specialist atai Life Sciences is to buy privately-held UK psychedelic drug developer Beckley ...
Japanese biotech Nxera Pharma (TSE: 4565) has received a $15 million payment from Neurocrine Biosciences (Nasdaq: NBIX) after ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved SFL Pharmaceuticals Deutschland’s Aumseqa (aumolertinib) for adults with non-small cell lung cancer (NSCLC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results